Rare diseases
Investigational molecules
Locations
27 Commerce Street, 07081-3014, United States
Evergreen Theragnostics Inc. focuses its clinical research on small cell lung cancer, with studies centered on advanced molecular imaging and targeted radiopharmaceutical development.
The sponsor’s research activity includes work with gallium-68-based and lutetium-177-based compounds relevant to tumor visualization and targeted treatment in lung cancer.
Evergreen Theragnostics Inc. runs clinical trials in conditions such as Small cell lung cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
